BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Inflammatory disorder
,
Pancreas
,
Holistic medicine
,
LEP
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ATG-18
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Dendritic (plasmacytoid) cell
Testes
Granulocyte-macrophage progenitor cell of bone marrow
Whole brain
Testis seminiferous tubule
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Perforation of tympanic membrane
Varicella-zoster virus infection
Microbial culture finding
Bacterial sepsis of newborn
Mental retardation
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
manganese chloride
Meglumine
furaltadon
Minocycline
Formalin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
OA1
ZNF804A
PTH
ARRB2
TXNL4B
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
STING recruits WIPI2 for autophagosome formation.
STING directly recruits WIPI2 for autophagosome formation during STING-induced autophagy.
ATG16L1 is equipped with two distinct WIPI2-binding sites to drive autophagy.
Atg21 organizes Atg8 lipidation at the contact of the vacuole with the phagophore.
Neuronal autophagy declines substantially with age and is rescued by overexpression of WIPI2.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
STOP-T1D Low-Dose (ATG)
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
Research Study of ATG and Rituximab in Renal Transplantation
Comparison of ATG to Thymoglobuline in Renal Transplantation
A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ